Ulcer aspirin combo drug, Axanum, gets EU approval
AstraZeneca today announced that AXANUM, a fixed dose combination of 81 mg low-dose ASA (acetylsalicylic acid) and 20 mg esomeprazole, has received positive agreement for approval in 23 European Union...
View ArticleThe leading cause of peptic ulcers is the subject of a new study from...
Virginia Tech researchers have developed a model that helps scientists and clinicians understand that complex interactions of a type of bacteria that is the leading cause of peptic ulcers. The...
View Article
More Pages to Explore .....
